Chronic Total Occlusion, Image, Revascularization
Conditions
Keywords
Chronic Total Occlusion, Cardiac magnetic resonance, Revascularization
Brief summary
This registry will include consecutive patients presenting with at least one chronic total occlusion on coronary angiogram who will be treated by percutaneous coronary intervention in our center. All patients will undergo a non-invasive assessment for myocardial ischemia/viability using cardiac magnetic resonance (CMR) prior to revascularization therapy. Follow up CMR will be repeated in all participants after three months and one year. Additionally, clinical outcomes and quality of life will be evaluated at baseline and at follow-up. Primary objective of this study is to investigate the the reduction in ischemia (as evaluated by follow-up CMR) and the severity of angina according to clinical evaluation (including Seattle Angina Questionnaires \[SAQ\], Canadian Class Score\[CCS\] and 6-mins walking test).
Interventions
PROCEDUREPercutaneous coronary intervention
Patients with a diagnose of coronary chronic total occlusions will be treated by percutaneous coronary intervention, as indicated by the heart-team.
Sponsors
Lin Zhao
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Age \> 18 years * Presence of at least one untreated CTO at basal angiography (defined as a total occlusion in any major coronary vessel or relevant side branches \[reference vessel diameter ≥2.5mm or as judged by two independent interventional cardiologists\], with TIMI 0 in the distal segment and at least 3 months old * Patient has a clinical indication to perform CTO PCI * Willing to participate and able to understand, read and sign the informed consent document.
Exclusion criteria
* CMR contraindications * Contraindications to adenosine or dobutamine * Severe chronic kidney disease (estimated Glomerular Filtration Rate \[eGFR\] \<60 mL/min/1.73m2 or serum creatinine level \>2.5 mg/dL)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in ischemia | 3 months; 12 months | Parameters of cardiac magnetic resonance |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Rate of target lesion failure (TLF). | 12 months | TLF is defined as a composite of: cardiac death, target vessel myocardial infarction (SCAI definition), and clinically driven TLR. |
| Changes in angina paramteres | 3 months; 12 months | Parameters of angina questionnaires. |
| Change of left ventricular structure and function | 3 months; 12 months | Parameters of left ventricular function and structure on cardiac magnetic resonance |
Countries
China
Contacts
Primary ContactXu Wang, MD
Outcome results
None listed